Showing 1,181 - 1,200 results of 101,552 for search '(( 5 we decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.52s Refine Results
  1. 1181
  2. 1182
  3. 1183
  4. 1184
  5. 1185

    GFRα2 expression was dramatically decreased in Runx1 knockout mice. by Ting Wang (16292)

    Published 2013
    “…*<i>p</i><0.05; t-test. <b>C</b>) Five days after sciatic nerve axotomy, Runx1 expression decreased in ipsilateral DRG (<b><i>C<sup>/</sup></i></b>) relative to contralateral DRG (<b><i>C</i></b>). …”
  6. 1186
  7. 1187
  8. 1188
  9. 1189

    Area V1 responses to illusory corner-folds in Vasarely’s nested squares and the Alternating Brightness Star illusions by Susana Martinez-Conde (389218)

    Published 2019
    “…<div><p>Vasarely’s nested squares illusion shows that the corners of concentric squares, arranged in a gradient of increasing or decreasing luminance, generate illusory “corner-folds,” which appear more salient (either brighter or darker) than the adjacent flat (non- corner) regions of each individual square. …”
  10. 1190

    Decreased Integrity, Content, and Increased Transcript Level of Mitochondrial DNA Are Associated with Keratoconus by Xiao-Dan Hao (215742)

    Published 2016
    “…The relative mtDNA content of KC corneas was significantly lower than that of normal corneas (<i>P</i> = 9.19×10<sup>−24</sup>), possibly due to decreased expression of the mitochondrial transcription factor A (<i>TFAM</i>) gene (<i>P</i> = 3.26×10<sup>−3</sup>). …”
  11. 1191

    The 2lox Lsd1 variant shows decreased binding to known interactors. by Thomas B. Nicholson (406800)

    Published 2013
    “…For the two single point mutants, the M448V mutation has a more profound effect on CoREST binding. *: immunoglobulin heavy chain. …”
  12. 1192

    Image_8_C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.JPEG by Quan-you Zheng (713217)

    Published 2019
    “…The lack of characterization of the pathogenesis of psoriasis has hindered efficient clinical treatment of the disease. In our study, we observed that expression of complement component 5a receptor 1(C5aR1) was significantly increased in skin lesions of both imiquimod (IMQ) and IL23-induced psoriatic mice and patients with psoriasis. …”
  13. 1193

    Image_2_C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.JPEG by Quan-you Zheng (713217)

    Published 2019
    “…The lack of characterization of the pathogenesis of psoriasis has hindered efficient clinical treatment of the disease. In our study, we observed that expression of complement component 5a receptor 1(C5aR1) was significantly increased in skin lesions of both imiquimod (IMQ) and IL23-induced psoriatic mice and patients with psoriasis. …”
  14. 1194

    Image_10_C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.JPEG by Quan-you Zheng (713217)

    Published 2019
    “…The lack of characterization of the pathogenesis of psoriasis has hindered efficient clinical treatment of the disease. In our study, we observed that expression of complement component 5a receptor 1(C5aR1) was significantly increased in skin lesions of both imiquimod (IMQ) and IL23-induced psoriatic mice and patients with psoriasis. …”
  15. 1195

    Image_9_C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.JPEG by Quan-you Zheng (713217)

    Published 2019
    “…The lack of characterization of the pathogenesis of psoriasis has hindered efficient clinical treatment of the disease. In our study, we observed that expression of complement component 5a receptor 1(C5aR1) was significantly increased in skin lesions of both imiquimod (IMQ) and IL23-induced psoriatic mice and patients with psoriasis. …”
  16. 1196

    Image_1_C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.JPEG by Quan-you Zheng (713217)

    Published 2019
    “…The lack of characterization of the pathogenesis of psoriasis has hindered efficient clinical treatment of the disease. In our study, we observed that expression of complement component 5a receptor 1(C5aR1) was significantly increased in skin lesions of both imiquimod (IMQ) and IL23-induced psoriatic mice and patients with psoriasis. …”
  17. 1197

    Image_3_C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.JPEG by Quan-you Zheng (713217)

    Published 2019
    “…The lack of characterization of the pathogenesis of psoriasis has hindered efficient clinical treatment of the disease. In our study, we observed that expression of complement component 5a receptor 1(C5aR1) was significantly increased in skin lesions of both imiquimod (IMQ) and IL23-induced psoriatic mice and patients with psoriasis. …”
  18. 1198

    Image_7_C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.JPEG by Quan-you Zheng (713217)

    Published 2019
    “…The lack of characterization of the pathogenesis of psoriasis has hindered efficient clinical treatment of the disease. In our study, we observed that expression of complement component 5a receptor 1(C5aR1) was significantly increased in skin lesions of both imiquimod (IMQ) and IL23-induced psoriatic mice and patients with psoriasis. …”
  19. 1199

    Image_4_C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.JPEG by Quan-you Zheng (713217)

    Published 2019
    “…The lack of characterization of the pathogenesis of psoriasis has hindered efficient clinical treatment of the disease. In our study, we observed that expression of complement component 5a receptor 1(C5aR1) was significantly increased in skin lesions of both imiquimod (IMQ) and IL23-induced psoriatic mice and patients with psoriasis. …”
  20. 1200

    Image_6_C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.JPEG by Quan-you Zheng (713217)

    Published 2019
    “…The lack of characterization of the pathogenesis of psoriasis has hindered efficient clinical treatment of the disease. In our study, we observed that expression of complement component 5a receptor 1(C5aR1) was significantly increased in skin lesions of both imiquimod (IMQ) and IL23-induced psoriatic mice and patients with psoriasis. …”